{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T05:58:51Z","timestamp":1785477531328,"version":"3.56.0"},"reference-count":76,"publisher":"Oxford University Press (OUP)","issue":"8","license":[{"start":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T00:00:00Z","timestamp":1773792000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003921","name":"Department of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003921","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,7,31]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:p>Monogenic diseases account for 10%\u201320% of chronic kidney disease (CKD) in adults. Their importance is increasingly appreciated in general nephrology, facilitated by more widespread access to genomic testing and expanding gene panels. The 2024 KDIGO clinical practice guideline for evaluation and management of CKD emphasizes the importance of considering genetic testing, particularly in the context of unexplained CKD (CKDx) when histological evaluation does not identify a precise aetiology. Identifying a genetic cause provides a definitive diagnosis and shapes patient management including access to disease-specific therapies, screening for extra-renal manifestations, early initiation of renoprotective measures, avoiding ineffective and potentially harmful treatments, a better understanding of the likely disease course including risk of recurrence following transplantation, and reproductive counselling. Despite this, genetic kidney disease may be overlooked due to lack of physician or pathologist familiarity, lack of clear family history, genotype\u2212phenotype heterogeneity, and\/or atypical presentations. The pathologist has an important role in identifying potential cases of genetic kidney disease as part of routine kidney biopsy assessment. Histology can either strengthen the case for a suspected genetic disease, or\u2014not infrequently\u2014be the first evidence of a potential underlying genetic cause. The pathologist participates in the clinicopathological correlation (CPC) meeting discussing evidence to identify patients in whom genetic testing would be appropriate. This review provides pathologists and nephrologists with an overview of the different histological patterns associated with genetic kidney disease, and outlines a practical framework for reporting kidney biopsies, receiving the reports, and\/or participating in CPC discussions.<\/jats:p>","DOI":"10.1093\/ndt\/gfag047","type":"journal-article","created":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T12:36:02Z","timestamp":1773837362000},"page":"1421-1428","source":"Crossref","is-referenced-by-count":0,"title":["Genetic kidney disease in adults\u2014the pathologists\u2019 perspective"],"prefix":"10.1093","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1494-0875","authenticated-orcid":false,"given":"Anna L","family":"Paterson","sequence":"first","affiliation":[{"name":"Cambridge University Hospitals Department of Histopathology, , Cambridge ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melanie M Y","family":"Chan","sequence":"additional","affiliation":[{"name":"Medical Research Council Laboratory of Medical Sciences, Imperial College London , London ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Candice","family":"Roufosse","sequence":"additional","affiliation":[{"name":"Imperial College Healthcare Trust Department of Histopathology, , London ,","place":["UK"]},{"name":"Imperial College London Department of Immunology and Inflammation, , London ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,3,18]]},"reference":[{"key":"2026073101114343100_bib1","doi-asserted-by":"publisher","first-page":"2039","DOI":"10.1681\/ASN.0000000000000249","article-title":"The clinical utility of genetic testing in the diagnosis and management of adults with chronic kidney disease","volume-title":"J Am Soc Nephrol","author":"Dahl","year":"2023"},{"key":"2026073101114343100_bib2","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1056\/NEJMoa1806891","article-title":"Diagnostic utility of exome sequencing for kidney disease","volume":"380","author":"Groopman","year":"2019","journal-title":"N Engl J Med"},{"key":"2026073101114343100_bib3","doi-asserted-by":"publisher","first-page":"eadp4753","DOI":"10.1126\/science.adp4753","article-title":"Kidney multiome-based genetic scorecard reveals convergent coding and regulatory variants","volume":"387","author":"Liu","year":"2025","journal-title":"Science"},{"key":"2026073101114343100_bib4","doi-asserted-by":"publisher","first-page":"ii3","DOI":"10.1093\/ndt\/gfad067","article-title":"The five types of glomerulonephritis classified by pathogenesis, activity and chronicity (GN-AC)","volume":"38","author":"Romagnani","year":"2023","journal-title":"Nephrol Dial Transplant"},{"key":"2026073101114343100_bib5","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1056\/NEJMra2308577","article-title":"Genetics of chronic kidney disease","volume":"391","author":"Vivante","year":"2024","journal-title":"N Engl J Med"},{"key":"2026073101114343100_bib6","doi-asserted-by":"publisher","first-page":"2390","DOI":"10.1093\/ndt\/gfaf092","article-title":"Chronic kidney disease of unexplained cause (CKDx): a consensus statement by the Genes & Kidney Working Group of the ERA","volume":"40","author":"Halbritter","year":"2025","journal-title":"Nephrol Dial Transplant"},{"key":"2026073101114343100_bib7","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1053\/j.ajkd.2025.07.005","article-title":"Quantifying APOL1, human leukocyte antigen, and other genetic contributions to unexplained kidney failure","volume":"86","author":"Sadeghi-Alavijeh","year":"2025","journal-title":"Am J Kidney Dis"},{"key":"2026073101114343100_bib8","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1097\/MNH.0000000000000983","article-title":"Alport syndrome and Alport kidney diseases\u2014elucidating the disease spectrum","volume":"33","author":"Puapatanakul","year":"2024","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"2026073101114343100_bib9","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1038\/s41581-020-0329-y","article-title":"Complexities of the glomerular basement membrane","volume":"17","author":"Naylor","year":"2021","journal-title":"Nat Rev Nephrol"},{"key":"2026073101114343100_bib10","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1093\/ndt\/gfae265","article-title":"Diagnosis, management and treatment of the Alport syndrome\u20132024 guideline on behalf of ERKNet, ERA and ESPN","volume":"40","author":"Torra","year":"2025","journal-title":"Nephrol Dial Transplant"},{"key":"2026073101114343100_bib11","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1681\/ASN.V114649","article-title":"X-linked Alport syndrome: natural history in 195 families and genotype- phenotype correlations in males","volume":"11","author":"Jais","year":"2000","journal-title":"J Am Soc Nephrol"},{"key":"2026073101114343100_bib12","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.1681\/ASN.2012100985","article-title":"COL4A3\/COL4A4 mutations and features in individuals with autosomal recessive Alport syndrome","volume":"24","author":"Storey","year":"2013","journal-title":"J Am Soc Nephrol"},{"key":"2026073101114343100_bib13","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1159\/000516744","article-title":"Hereditary nephritis and thin glomerular basement membrane lesion","volume":"1","author":"Lusco","year":"2021","journal-title":"Glomerular Dis"},{"key":"2026073101114343100_bib14","doi-asserted-by":"publisher","first-page":"3201","DOI":"10.1007\/s00467-025-06802-5","article-title":"Kidney pathological findings of MYH9-related disease: a cross-sectional nationwide survey in Japan","volume":"40","author":"Nakatani","year":"2025","journal-title":"Pediatr Nephrol"},{"key":"2026073101114343100_bib15","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1007\/s00467-022-05634-x","article-title":"Focal segmental glomerulosclerosis and proteinuria associated with Myo1E mutations: novel variants and histological phenotype analysis","volume":"38","author":"Krendel","year":"2023","journal-title":"Pediatr Nephrol"},{"key":"2026073101114343100_bib16","doi-asserted-by":"publisher","first-page":"2687","DOI":"10.1056\/NEJMoa071906","article-title":"COL4A1 mutations and hereditary angiopathy, nephropathy, aneurysms, and muscle cramps","volume":"357","author":"Plaisier","year":"2007","journal-title":"N Engl J Med"},{"key":"2026073101114343100_bib17","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3109\/01913128809048473","article-title":"Ultrastructural changes of glomerular basement membrane in IgA nephritis: relationship to hematuria","volume":"12","author":"Taguchi","year":"1988","journal-title":"Ultrastruct Pathol"},{"key":"2026073101114343100_bib18","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1007\/s10157-014-1008-8","article-title":"Glomerular basement membrane injuries in IgA nephropathy evaluated by double immunostaining for \u03b15(IV) and \u03b12(IV) chains of type IV collagen and low-vacuum scanning electron microscopy","volume":"19","author":"Masuda","year":"2015","journal-title":"Clin Exp Nephrol"},{"key":"2026073101114343100_bib19","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1681\/ASN.2021111447","article-title":"Genetic variants of the COL4A3, COL4A4, and COL4A5 genes contribute to thinned glomerular basement membrane lesions in sporadic IgA nephropathy patients","volume":"34","author":"Yuan","year":"2023","journal-title":"J Am Soc Nephrol"},{"key":"2026073101114343100_bib20","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1016\/j.ekir.2020.04.011","article-title":"Type IV collagen mutations in familial IgA nephropathy","volume":"5","author":"Li","year":"2020","journal-title":"Kidney Int Rep"},{"key":"2026073101114343100_bib21","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1159\/000526971","article-title":"Collagen IV and podocyte-related gene variants in patients with concurrent IgA nephropathy and thin basement membrane nephropathy","volume":"147","author":"Xu","year":"2023","journal-title":"Nephron"},{"key":"2026073101114343100_bib22","doi-asserted-by":"publisher","first-page":"2273","DOI":"10.1681\/ASN.2020071065","article-title":"Prevalence estimates of predicted pathogenic COL4A3-COL4A5 variants in a population sequencing database and their implications for Alport syndrome","volume":"32","author":"Gibson","year":"2021","journal-title":"J Am Soc Nephrol"},{"key":"2026073101114343100_bib23","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1136\/jmg.2009.072116","article-title":"Screening for Fabry disease in high-risk populations: a systematic review","volume":"47","author":"Linthorst","year":"2010","journal-title":"J Med Genet"},{"key":"2026073101114343100_bib24","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1111\/j.1365-2362.2004.01309.x","article-title":"Fabry disease defined: baseline clinical manifestations of 366 patients in the Fabry Outcome Survey","volume":"34","author":"Mehta","year":"2004","journal-title":"Eur J Clin Investigation"},{"key":"2026073101114343100_bib25","doi-asserted-by":"publisher","first-page":"2743","DOI":"10.1001\/jama.285.21.2743","article-title":"Enzyme replacement therapy in Fabry disease: a randomized controlled trial","volume":"285","author":"Schiffmann","year":"2001","journal-title":"JAMA"},{"key":"2026073101114343100_bib26","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.5858\/arpa.2016-0418-RS","article-title":"Fabry Nephropathy","volume":"141","author":"Colpart","year":"2017","journal-title":"Arch Pathol Lab Med"},{"key":"2026073101114343100_bib27","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1681\/ASN.2009080808","article-title":"Phenotype and genotype characterization of adenine phosphoribosyltransferase deficiency","volume":"21","author":"Boll\u00e9e","year":"2010","journal-title":"J Am Soc Nephrol"},{"key":"2026073101114343100_bib28","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1016\/j.ekir.2019.04.021","article-title":"Adenine phosphoribosyltransferase deficiency: a potentially reversible cause of CKD","volume":"4","author":"Li","year":"2019","journal-title":"Kidney Int Rep"},{"key":"2026073101114343100_bib29","doi-asserted-by":"publisher","first-page":"e946972","DOI":"10.12659\/AJCR.946972","article-title":"Crystalline nephropathy due to 2,8-dihydroxyadeninuria in a transplanted kidney: 2 case reports","volume":"26","author":"Raza","year":"2025","journal-title":"Am J Case Rep"},{"key":"2026073101114343100_bib30","doi-asserted-by":"publisher","first-page":"2120","DOI":"10.1097\/TP.0000000000003088","article-title":"Kidney transplant outcomes in patients with adenine phosphoribosyltransferase deficiency","volume":"104","author":"Runolfsdottir","year":"2020","journal-title":"Transplantation"},{"key":"2026073101114343100_bib31","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1053\/j.ajkd.2019.03.422","article-title":"The P274S mutation of lecithin-cholesterol acyltransferase (LCAT) and its clinical manifestations in a large kindred","volume":"74","author":"Fountoulakis","year":"2019","journal-title":"Am J Kidney Dis"},{"key":"2026073101114343100_bib32","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1007\/s40620-022-01459-x","article-title":"A rare case of renal involvement in lecithin-cholesterol acyltransferase (LCAT) deficiency: lessons for the clinical nephrologist","volume":"36","author":"Rath","year":"2023","journal-title":"J Nephrol"},{"key":"2026073101114343100_bib33","doi-asserted-by":"crossref","first-page":"139","DOI":"10.3109\/01913123.2010.551578","article-title":"Lecithin: cholesterol acyltransferase (LCAT) deficiency: renal lesions with early graft recurrence","volume":"35","author":"Str\u00f8m","year":"2011","journal-title":"Ultrastruct Pathol"},{"key":"2026073101114343100_bib34","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1007\/s10157-013-0895-4","article-title":"Characteristic kidney pathology, gene abnormality and treatments in LCAT deficiency","volume":"18","author":"Hirashio","year":"2014","journal-title":"Clin Exp Nephrol"},{"key":"2026073101114343100_bib35","doi-asserted-by":"publisher","first-page":"e5","DOI":"10.1053\/j.ajkd.2017.05.003","article-title":"AJKD Atlas of Renal Pathology: lecithin-cholesterol acyltransferase (LCAT) deficiency","volume":"70","author":"Najafian","year":"2017","journal-title":"Am J Kidney Dis"},{"key":"2026073101114343100_bib36","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1016\/j.jacl.2018.05.002","article-title":"Immune-mediated acquired lecithin-cholesterol acyltransferase deficiency: a case report and literature review","volume":"12","author":"Ishibashi","year":"2018","journal-title":"J Clin Lipidol"},{"key":"2026073101114343100_bib37","doi-asserted-by":"publisher","first-page":"942","DOI":"10.2215\/CJN.11830720","article-title":"Inherited kidney complement diseases","volume":"16","author":"Lemaire","year":"2021","journal-title":"Clin J Am Soc Nephrol"},{"key":"2026073101114343100_bib38","doi-asserted-by":"publisher","first-page":"1460146","DOI":"10.3389\/fneph.2024.1460146","article-title":"C3 glomerulopathy: a kidney disease mediated by alternative pathway deregulation","volume":"4","author":"Heidenreich","year":"2024","journal-title":"Front Nephrol"},{"key":"2026073101114343100_bib39","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.ekir.2024.09.017","article-title":"Challenges in the diagnosis and management of immune complex-mediated membranoproliferative glomerulonephritis and complement 3 glomerulopathy","volume":"10","author":"Bomback","year":"2024","journal-title":"Kidney Int Reps"},{"key":"2026073101114343100_bib40","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1053\/j.ajkd.2022.10.014","article-title":"Renal thrombotic microangiopathy: a review","volume":"81","author":"Genest","year":"2023","journal-title":"Am J Kidney Dis"},{"key":"2026073101114343100_bib41","doi-asserted-by":"publisher","first-page":"1826","DOI":"10.1093\/ndt\/gfaf042","article-title":"The evolving spectrum of kidney amyloidosis: advances in diagnosis, typing and treatment","volume":"40","author":"Allinovi","year":"2025","journal-title":"Nephrol Dial Transplant"},{"key":"2026073101114343100_bib42","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1681\/ASN.2008060614","article-title":"Diagnosis, pathogenesis, treatment, and prognosis of hereditary fibrinogen A alpha-chain amyloidosis","volume":"20","author":"Gillmore","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"2026073101114343100_bib43","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1681\/ASN.2008070813","article-title":"Nephrotic syndrome due to an amyloidogenic mutation in fibrinogen A alpha chain","volume":"20","author":"Picken","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"2026073101114343100_bib44","doi-asserted-by":"publisher","first-page":"1786","DOI":"10.1056\/NEJMoa013354","article-title":"Misdiagnosis of hereditary amyloidosis as AL (primary) amyloidosis","volume":"346","author":"Lachmann","year":"2002","journal-title":"N Engl J Med"},{"key":"2026073101114343100_bib45","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1093\/ckj\/sfab145","article-title":"Oxalate nephropathy: a review","volume":"15","author":"Rosenstock","year":"2021","journal-title":"Clin Kidney J"},{"key":"2026073101114343100_bib46","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1038\/ki.2009.435","article-title":"Genotype-phenotype correlation in primary hyperoxaluria type 1: the p.Gly170Arg AGXT mutation is associated with a better outcome","volume":"77","author":"Harambat","year":"2010","journal-title":"Kidney Int"},{"key":"2026073101114343100_bib47","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.kint.2022.07.025","article-title":"PHYOX2: a pivotal randomized study of nedosiran in primary hyperoxaluria type 1 or 2","volume":"103","author":"Baum","year":"2023","journal-title":"Kidney Int"},{"key":"2026073101114343100_bib48","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1056\/NEJMoa2021712","article-title":"Lumasiran, an RNAi therapeutic for primary hyperoxaluria type 1","volume":"384","author":"Garrelfs","year":"2021","journal-title":"N Engl J Med"},{"key":"2026073101114343100_bib49","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1093\/ndt\/gfac295","article-title":"Isolated kidney transplantation under lumasiran therapy in primary hyperoxaluria type 1: a report of five cases","volume":"38","author":"Sellier-Leclerc","year":"2023","journal-title":"Nephrol Dial Transplant"},{"key":"2026073101114343100_bib50","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1038\/ng.2347","article-title":"FAN1 mutations cause karyomegalic interstitial nephritis, linking chronic kidney failure to defective DNA damage repair","volume":"44","author":"Zhou","year":"2012","journal-title":"Nat Genet"},{"key":"2026073101114343100_bib51","doi-asserted-by":"publisher","first-page":"41","DOI":"10.5414\/CNCS111727","article-title":"Karyomegalic interstitial nephritis: a case series and review of the literature on genetic insights and clinical challenges","volume":"13","author":"Ozcan","year":"2025","journal-title":"Clin Nephrol Case Studies"},{"key":"2026073101114343100_bib52","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1681\/ASN.2017090958","article-title":"Differentiating primary, genetic, and secondary FSGS in adults: a clinicopathologic approach","volume":"29","author":"De\u00a0Vriese","year":"2018","journal-title":"J Am Soc Nephrol"},{"key":"2026073101114343100_bib53","doi-asserted-by":"publisher","first-page":"2342","DOI":"10.1016\/j.mayocp.2021.01.037","article-title":"Identification of genetic causes of focal segmental glomerulosclerosis increases with proper patient selection","volume":"96","author":"Miao","year":"2021","journal-title":"Mayo Clin Proc"},{"key":"2026073101114343100_bib54","doi-asserted-by":"publisher","first-page":"213","DOI":"10.2215\/CJN.08750718","article-title":"Integration of genetic testing and pathology for the diagnosis of adults with FSGS","volume":"14","author":"Yao","year":"2019","journal-title":"Clin J Am Soc Nephrol"},{"key":"2026073101114343100_bib55","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1038\/73456","article-title":"Mutations in ACTN4, encoding alpha-actinin-4, cause familial focal segmental glomerulosclerosis","volume":"24","author":"Kaplan","year":"2000","journal-title":"Nat Genet"},{"key":"2026073101114343100_bib56","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1038\/ng.505","article-title":"Mutations in the formin gene INF2 cause focal segmental glomerulosclerosis","volume":"42","author":"Brown","year":"2010","journal-title":"Nat Genet"},{"key":"2026073101114343100_bib57","doi-asserted-by":"publisher","first-page":"1801","DOI":"10.1126\/science.1106215","article-title":"A mutation in the TRPC6 cation channel causes familial focal segmental glomerulosclerosis","volume":"308","author":"Winn","year":"2005","journal-title":"Science"},{"key":"2026073101114343100_bib58","doi-asserted-by":"publisher","first-page":"1659","DOI":"10.1172\/JCI0216242","article-title":"NPHS2 mutations in late-onset focal segmental glomerulosclerosis: R229Q is a common disease-associated allele","volume":"110","author":"Tsukaguchi","year":"2002","journal-title":"J Clin Invest"},{"key":"2026073101114343100_bib59","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1038\/ki.2015.28","article-title":"Autosomal dominant tubulointerstitial kidney disease: diagnosis, classification, and management\u2014a KDIGO consensus report","volume":"88","author":"Eckardt","year":"2015","journal-title":"Kidney Int"},{"key":"2026073101114343100_bib60","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1016\/j.kint.2020.04.038","article-title":"Clinical and genetic spectra of autosomal dominant tubulointerstitial kidney disease due to mutations in UMOD and MUC1","volume":"98","author":"Olinger","year":"2020","journal-title":"Kidney Int"},{"key":"2026073101114343100_bib61","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1038\/ng.2543","article-title":"Mutations causing medullary cystic kidney disease type 1 lie in a large VNTR in MUC1 missed by massively parallel sequencing","volume":"45","author":"Kirby","year":"2013","journal-title":"Nat Genet"},{"key":"2026073101114343100_bib62","doi-asserted-by":"publisher","first-page":"107171","DOI":"10.1016\/j.isci.2023.107171","article-title":"VNtyper enables accurate alignment-free genotyping of MUC1 coding VNTR using short-read sequencing data in autosomal dominant tubulointerstitial kidney disease","volume":"26","author":"Saei","year":"2023","journal-title":"iScience"},{"key":"2026073101114343100_bib63","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1053\/j.ajkd.2024.11.010","article-title":"Phenotypic heterogeneity of ADTKD-MUC1 diagnosed using VNtyper, a novel genetic technique","volume":"85","author":"Kachmar","year":"2025","journal-title":"American Journal of Kidney Diseases"},{"key":"2026073101114343100_bib64","doi-asserted-by":"publisher","first-page":"2298","DOI":"10.1681\/ASN.2018030245","article-title":"Biallelic expression of mucin-1 in autosomal dominant tubulointerstitial kidney disease: implications for nongenetic disease recognition","volume":"29","author":"Knaup","year":"2018","journal-title":"J Am Soc Nephrol"},{"key":"2026073101114343100_bib65","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1016\/j.kint.2023.05.007","article-title":"The genetic landscape and clinical spectrum of nephronophthisis and related ciliopathies","volume":"104","author":"Petzold","year":"2023","journal-title":"Kidney Int"},{"key":"2026073101114343100_bib66","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.1016\/j.ekir.2022.05.035","article-title":"Refining kidney survival in 383 genetically characterized patients with nephronophthisis","volume":"7","author":"K\u00f6nig","year":"2022","journal-title":"Kidney Int Rep"},{"key":"2026073101114343100_bib67","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1016\/j.ekir.2021.02.005","article-title":"Genetic background and clinicopathologic features of adult-onset nephronophthisis","volume":"6","author":"Fujimaru","year":"2021","journal-title":"Kidney Int Rep"},{"key":"2026073101114343100_bib68","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1126\/science.1193032","article-title":"Association of trypanolytic ApoL1 variants with kidney disease in African Americans","volume":"329","author":"Genovese","year":"2010","journal-title":"Science"},{"key":"2026073101114343100_bib69","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1007\/s00439-010-0861-0","article-title":"Missense mutations in the APOL1 gene are highly associated with end stage kidney disease risk previously attributed to the MYH9 gene","volume":"128","author":"Tzur","year":"2010","journal-title":"Hum Genet"},{"key":"2026073101114343100_bib70","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1056\/NEJMoa2404211","article-title":"APOL1 bi- and monoallelic variants and chronic kidney disease in West Africans","volume":"392","author":"Gbadegesin","year":"2025","journal-title":"N Engl J Med"},{"key":"2026073101114343100_bib71","doi-asserted-by":"publisher","first-page":"114310","DOI":"10.1016\/j.celrep.2024.114310","article-title":"Interferon-\u03b3 induces combined pyroptotic angiopathy and APOL1 expression in human kidney disease","volume":"43","author":"Juliar","year":"2024","journal-title":"Cell Rep"},{"key":"2026073101114343100_bib72","first-page":"S0085","article-title":"APOL1 kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference","author":"Ojo","year":"2025","journal-title":"Kidney Int"},{"key":"2026073101114343100_bib73","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1016\/j.kint.2018.06.024","article-title":"Donor APOL1 high-risk genotypes are associated with increased risk and inferior prognosis of de novo collapsing glomerulopathy in renal allografts","volume":"94","author":"Santoriello","year":"2018","journal-title":"Kidney Int"},{"key":"2026073101114343100_bib74","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1681\/ASN.2012121180","article-title":"Apolipoprotein L1 risk variants associate with systemic lupus erythematosus-associated collapsing glomerulopathy","volume":"24","author":"Larsen","year":"2013","journal-title":"J Am Soc Nephrol"},{"key":"2026073101114343100_bib75","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1053\/j.ajkd.2014.02.024","article-title":"Histopathologic effect of APOL1 risk alleles in PLA2R-associated membranous glomerulopathy","volume":"64","author":"Larsen","year":"2014","journal-title":"Am J Kidney Dis"},{"key":"2026073101114343100_bib76","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1038\/modpathol.2014.92","article-title":"Histopathologic findings associated with APOL1 risk variants in chronic kidney disease","volume":"28","author":"Larsen","year":"2015","journal-title":"Mod Pathol"}],"container-title":["Nephrology Dialysis Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ndt\/advance-article-pdf\/doi\/10.1093\/ndt\/gfag047\/67389909\/gfag047.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ndt\/article-pdf\/41\/8\/1421\/67389909\/gfag047.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ndt\/article-pdf\/41\/8\/1421\/67389909\/gfag047.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T05:11:48Z","timestamp":1785474708000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ndt\/article\/41\/8\/1421\/8527595"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,18]]},"references-count":76,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2026,3,18]]},"published-print":{"date-parts":[[2026,7,31]]}},"URL":"https:\/\/doi.org\/10.1093\/ndt\/gfag047","relation":{},"ISSN":["0931-0509","1460-2385"],"issn-type":[{"value":"0931-0509","type":"print"},{"value":"1460-2385","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,8]]},"published":{"date-parts":[[2026,3,18]]}}}